Cross-Protective Immunity against O`Nyong-nyong Virus Afforded by a Novel Recombinant Chikungunya Vaccine

Emerging mosquito-borne alphavirus infections caused by chikungunya virus (CHIKV) oro`nyong-nyong virus (ONNV) are responsible for sporadic and sometimes explosive urban outbreaks. Currently, there is no licensed vaccine against either virus. We have developed a highly attenuated recombinant CHIKV c...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Partidos, Charalambos D., Paykel, Joanna, Weger, James, Borland, Erin M., Powers, Ann M., Seymour, Robert, Weaver, Scott C., Stinchcomb, Dan T., Osorio, Jorge E.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3372665/
https://ncbi.nlm.nih.gov/pubmed/22583812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.04.099
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items